Orchestra BioMed (Nasdaq:OBIO) today announced the pricing of an underwritten public offering totaling proceeds of ...

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Baxter (NYSE: BAX) + shares fell sharply today on second-quarter results that came up shy of the consensus forecast. Shares ...

Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB).

Vicarious Surgical (NYSE:RBOT) announced today that it appointed Stephen From as CEO, effective Aug. 7, 2025. Adam Sachs, ...

EvoEndo announced today that it received expanded FDA clearance for its Model LE gastroscope, covering patients of all ages.

InspireMD (Nasdaq:NSPR) announced today that it raised approximately $58 million and added an experienced executive to its ...

SetPoint Medical announced today that the FDA approved its SetPoint neuroimmune modulation system for treating rheumatoid ...

Last year was the first year that Drug Delivery Business News published a list of the world’s largest diabetes tech companies ...

Stryker will increase its full-year guidance after a Street-beating second quarter that saw strong demand for products and continued business momentum.

Sava Technologies could be bringing another glucose biosensor to the competitive continuous glucose monitor (CGM) market.